Authors


Cynthia Pullinger

Latest:

Supplier-Change Management for Drug-Product Manufacturers

An effective supplier-initiated change management process is discussed.




Elizabeth Oslos

Latest:

A Case Study of Developing Analytical Methods

Contract manufacturers must plan for increased analytical resources in development and quality control.


Arun Tholudur

Latest:

Considerations in Identification and Qualification of Spectrophotometer Equipment for Microbial Fermentations

The authors outline qualification procedures for a process-critical piece of equipment.


Howard Bland

Latest:

Successful Technology Transfer, Process Validation, and Partnership with a CMO

The authors present lessons learned from a case study of the transfer of a cell culture biotherapeutic process to a CMO.


Ben Berkhout

Latest:

Evolution of Live-Attenuated HIV Vaccines

Safety concerns remain for developing replicating vectors based on the pathogen human immunodeficiency virus type 1.


Bhaskar Mazumder

Latest:

Virosomes: A Novel Strategy for Drug Delivery and Targeting

Virosomes present novel drug-delivery vehicles with distinct advantages over liposomes.


Pierre Douette

Latest:

Sponsor-CMO Conflict Management for Clinical-Phase Biologics

The authors present the CMO's perspective on various potential sources of sponsor-CMO conflicts.


S. Fisch

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.


John J.S. Cadwell

Latest:

The Potential Application of Hollow Fiber Bioreactors to Large-Scale Production

A hollow fiber matrix allows for efficient harvest of secreted proteins.


Rebecca Arvary

Latest:

Automated Concentration and Diafiltration of Multiple siRNA Samples

Project: transfer a manual concentration/diafiltration process for siRNA production.


Dell Farnan, PhD

Latest:

High-Throughput Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies

These new analytical methods can reduce analysis and product development time.


S. Gerby

Latest:

Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors

A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.



Marc Andre D'Aoust

Latest:

Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution

A plant-based expression system could provide greater speed and capacity at a comparatively low cost.


Carin Gray

Latest:

Considerations in Identification and Qualification of Spectrophotometer Equipment for Microbial Fermentations

The authors outline qualification procedures for a process-critical piece of equipment.


Yi Zhang

Latest:

Identification and Quantification of Trace-Level Protein Impurities

A simple, sensitive, and universal platform for identification and quantification of trace-level protein impurities in biotherapeutics is described.


Neyda Hernández Caso

Latest:

Definition of a Security Value Determined by Limulus Amebocyte Lysate Assay Targeting the Recombinant Human Epidermal Growth Factor

The correlation between limulus amebocyte lysate (LAL) assay and rabbit pyrogen test (RPT) targeting recombinant human epidermal growth factor (rhEGF) as active molecule was assessed.


Katriona Scoffin

Latest:

Quantitative Post-Processing Characterization Techniques for Freeze-Dried Products

Subjective visual evaluation of freeze-dried products can be quantified through mechanical methods of characterizing the properties these materials.



Laura Ciccolini, PhD

Latest:

Lyophilization: A Primer

Optimized freeze-drying cycles can offer scientific and business advantages.


Kevin Murphy

Latest:

Patents and Postapproval Batch Testing

Can postapproval FDA filings immunize pharma companies from patent lawsuits?


Alex Eon-Duval

Latest:

Large-Scale Manufacturing of Plasmid DNA for Gene Therapy and DNA Vaccination -- Part 2: Toward an RNase-Free Downstream Process ? A Review

The medical benefits of transgenes - effective against diseases such as cancer, HIV, malaria, and tuberculosis - require either a viral or nonviral vector. Nonviral vectors have lower immunogenicity, better safety profiles, and improved stability, as well as being less expensive and easier to produce. The first article in this series reviewed techniques suitable for the purification of plasmid DNA in the absence of added RNase. This article investigates a downstream process capable of producing gram quantities of pure plasmid DNA.



Varsha Joshi

Latest:

Aggregation of Monoclonal Antibody Products: Formation and Removal

Aggregate formation is influenced by multiple aspects of the bioproduction process but can be mitigated by good process design and control.


Neethu Sunil

Latest:

Growth Kinetics of Human Mesenchymal Stem Cells in a 3-L Single-Use, Stirred-Tank Bioreactor

The authors describe the growth characteristics of human mesenchymal stem cells cultured in a stirred-tank bioreactor.



Rachel Thornton

Latest:

Integrating CMC Document Preparation into the Development Process for Vaccine INDs

Vaccine process development is complex, and so are the documents required before clinical trials begin. Technical writers and editors can effectively coordinate the timely authoring, reviewing, and auditing of regulatory documents, minimizing filing delays.


Roxana Hernández González

Latest:

Definition of a Security Value Determined by Limulus Amebocyte Lysate Assay Targeting the Recombinant Human Epidermal Growth Factor

The correlation between limulus amebocyte lysate (LAL) assay and rabbit pyrogen test (RPT) targeting recombinant human epidermal growth factor (rhEGF) as active molecule was assessed.

© 2025 MJH Life Sciences

All rights reserved.